NCT06099821 2023-10-26KN046 Plus Regorafenib or Apatinib in MSI-H Digestive System Cancers Resistant to PD-1/PD-L1 BlockadePeking University Cancer Hospital & InstitutePhase 2 Recruiting39 enrolled